Loratadine And Pseudoephedrine Sulfate Tablet, Film Coated, Extended Release
NDC Package 56062-724-69

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Loratadine And Pseudoephedrine Sulfate tablets is do not divide, crush, chew or dissolve the tablet adults and children 12 years and over 1 tablet daily with a full glass of water; not more than 1 tablet in 24 hours children under 12 years of age ask a doctor consumers with liver or kidney disease ask a doctor. This formulation utilizes a tablet, film coated, extended release delivery system. Marketed by Publix Super Markets Inc, this product is identified by NDC 56062-724 and is authorized under FDA application ANDA076557.

Identification & Billing

NDC Package Code
56062-724-69
Package Description
10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
Product Code
56062-724
11-Digit Billing Format
56062072469
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
10 EA
RxNorm Crosswalk
  • RxCUI: 1117562 - pseudoephedrine sulfate 240 MG / loratadine 10 MG 24HR Extended Release Oral Tablet
  • RxCUI: 1117562 - 24 HR loratadine 10 MG / pseudoephedrine sulfate 240 MG Extended Release Oral Tablet
  • RxCUI: 1117562 - loratadine 10 MG / pseudoephedrine sulfate 240 MG 24 HR Extended Release Oral Tablet

Clinical Specifications

Proprietary Name
Loratadine And Pseudoephedrine Sulfate
Non-Proprietary Name
Loratadine And Pseudoephedrine Sulfate
Substance Name
Loratadine; Pseudoephedrine Sulfate
Dosage Form
Tablet, Film Coated, Extended Release - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Do not divide, crush, chew or dissolve the tablet adults and children 12 years and over 1 tablet daily with a full glass of water; not more than 1 tablet in 24 hours children under 12 years of age ask a doctor consumers with liver or kidney disease ask a doctor

Regulatory & Marketing

Labeler Name
Publix Super Markets Inc
Product Type
Human Otc Drug
FDA Application #
ANDA076557
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-17-2004
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (56062-724). Click a package code to view its specific billing and regulatory data.

56062-724-15
15 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 56062-724-69 identifies a specific commercial package of 10 tablet, film coated, extended release in 1 blister pack of Loratadine And Pseudoephedrine Sulfate, a human over the counter drug labeled by Publix Super Markets Inc. This product is billed for "EA" each discreet unit and contains an estimated amount of 10 billable units per package. This tablet, film coated, extended release is formulated for oral use and contains loratadine; pseudoephedrine sulfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Publix Super Markets Inc on November 17, 2004. The current certification is valid through December 31, 2026.

How is this Publix Super Markets Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 56062072469. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
56062-724-69
11-Digit CMS (5-4-2)
56062-0724-69

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.